E-LIB Suche - Ergebnisse für: T'Sas, Sara

1

Myb overexpression synergizes with the loss of Pten and is ..:

Almeida, André ; T'Sas, Sara ; Pagliaro, Luca...
HemaSphere. 8 (2024) 3 - p. , 2024

Link: https://doi.org/10.1002/..

2

Pre-Clinical Evaluation of the Hypomethylating Agent Decita..:

Provez, Lien ; Putteman, Tom ; Landfors, Mattias...
Cancers. 15 (2023) 3 - p. 647 , 2023

Link: https://doi.org/10.3390/..

3

Myb drives B-cell neoplasms and myeloid malignancies in viv:

Pieters, Tim ; Almeida, André ; T'Sas, Sara...
Blood Advances. 6 (2022) 10 - p. 2987-2991 , 2022

Link: https://doi.org/10.1182/..

4

Cyclin D2 overexpression drives B1a-derived MCL-like lympho..:

Pieters, Tim ; T'Sas, Sara ; Vanhee, Stijn...
Journal of Experimental Medicine. 218 (2021) 10 - p. , 2021

Link: https://doi.org/10.1084/..

5

Direct and indirect anti-leukemic properties of activity-on..:

Goossens, Steven ; Cauwels, Anje ; Pieters, Tim...
Haematologica. 107 (2021) 6 - p. 1448-1453 , 2021

Link: https://doi.org/10.3324/..

6

Novel strategy for rapid functional in vivo validation of o..:

Pieters, Tim ; T'Sas, Sara ; Demoen, Lisa...
Scientific Reports. 9 (2019) 1 - p. , 2019

Link: https://doi.org/10.1038/..

7

Pre-clinical evaluation of the hypomethylating agent decita..:

Provez, Lien ; Putteman, Tom ; Landfors, Mattias...
Cancers, 2072-6694, 2023, 15:3,. , 2023

Link: http://urn.kb.se/resolve..

8

Pre-Clinical Evaluation of the Hypomethylating Agent Decita..:

Provez, Lien ; Putteman, Tom ; Landfors, Mattias...
https://discovery.ucl.ac.uk/id/eprint/10168985/1/Pre-Clinical%20Evaluation%20of%20the%20Hypomethylating%20Agent%20Decitabine%20for%20the%20Treatment%20of%20T-Cell%20Lymphoblastic%20Lymphoma.pdf. , 2023

Link: https://discovery.ucl.ac..

9

Myb drives B-cell neoplasms and myeloid malignancies in viv:

Pieters, Tim ; Almeida, André ; T'Sas, Sara...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9131915/. , 2022

Link: http://www.ncbi.nlm.nih...

10

Cyclin D2 overexpression drives B1a-derived MCL-like lympho..:

Pieters, Tim ; T'Sas, Sara ; Vanhee, Stijn...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8377631/. , 2021

Link: http://www.ncbi.nlm.nih...

11

Direct and indirect anti-leukemic properties of activity-on..:

Goossens, Steven ; Cauwels, Anje ; Pieters, Tim...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9152961/. , 2021

Link: http://www.ncbi.nlm.nih...

12

Novel strategy for rapid functional in vivo validation of o..:

Pieters, Tim ; T'Sas, Sara ; Demoen, Lisa...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6646380/. , 2019

Link: http://www.ncbi.nlm.nih...

13

ZEB2 and LMO2 drive immature T-cell lymphoblastic leukemia ..:

Goossens, Steven ; Wang, Jueqiong ; Tremblay, Cedric S...
Goossens , S , Wang , J , Tremblay , C S , De Medts , J , T'sas , S , Nguyen , T , Saw , J , Haigh , K , Curtis , D J , Van Vlierberghe , P , Berx , G , Taghon , T & Haigh , J J 2019 , ' ZEB2 and LMO2 drive immature T-cell lymphoblastic leukemia via distinct oncogenic mechanisms ' , Haematologica , vol. 104 , no. 8 , pp. 1608-1616 . https://doi.org/10.3324/haematol.2018.207837. , 2019

Link: https://research.monash...

14

Pre-Clinical Evaluation of the Hypomethylating Agent Decita..:

Lien Provez ; Tom Putteman ; Mattias Landfors...
https://www.mdpi.com/2072-6694/15/3/647. , 2023

Link: https://doi.org/10.3390/..

15

Pre-Clinical Evaluation of the Hypomethylating Agent Decita..:

Lien Provez ; Tom Putteman ; Mattias Landfors...
https://dx.doi.org/10.3390/cancers15030647. , 2023

Link: https://doi.org/10.3390/..